This is a Validated Antibody Database (VAD) review about Rhesus mon.. CTLA4, based on 10 published articles (read how Labome selects the articles), using CTLA4 antibody in all methods. It is aimed to help Labome visitors find the most suited CTLA4 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CTLA4 synonym: CTLA-4; cytotoxic T-lymphocyte protein 4; CD152 protein; cytotoxic T-lymphocyte protein 4 isoform CTLA4-TM

Invitrogen
mouse monoclonal (14D3)
  • immunohistochemistry - paraffin section; human; 1:100; fig 1
  • western blot; human; loading ...; fig s1
In order to investigate the expression of CTLA-4 in the non-small cell lung cancer and its prognostic impact, Invitrogen CTLA4 antibody (eBioscience, 14-1529) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1) and in western blot on human samples (fig s1). Cancer Immunol Immunother (2017) ncbi
mouse monoclonal (14D3)
  • immunohistochemistry - frozen section; human; loading ...; fig 5b
In order to describe and evaluate pituitary glands from cancer patients treated with CTLA-4 blockade, Invitrogen CTLA4 antibody (eBioscience, 14D3) was used in immunohistochemistry - frozen section on human samples (fig 5b). Am J Pathol (2016) ncbi
mouse monoclonal (14D3)
  • flow cytometry; human; loading ...; fig 3c
In order to report that patients with PTEN mutations experience autoimmunity and lymphoid hyperplasia, Invitrogen CTLA4 antibody (eBioscience, 14D3) was used in flow cytometry on human samples (fig 3c). J Allergy Clin Immunol (2017) ncbi
mouse monoclonal (14D3)
  • flow cytometry; Rhesus monkey; fig 2
Invitrogen CTLA4 antibody (eBioscience, 46-1529) was used in flow cytometry on Rhesus monkey samples (fig 2). Nat Commun (2015) ncbi
mouse monoclonal (14D3)
  • flow cytometry; human; fig 7
Invitrogen CTLA4 antibody (eBioscience, 14D3) was used in flow cytometry on human samples (fig 7). Haematologica (2016) ncbi
mouse monoclonal (14D3)
  • flow cytometry; human
In order to learn about stoichiometry of membrane proteins by single-molecule localization microscopy, Invitrogen CTLA4 antibody (eBioscience, 14D3) was used in flow cytometry on human samples . Sci Rep (2015) ncbi
mouse monoclonal (14D3)
  • blocking or activating experiments; human; fig 7
Invitrogen CTLA4 antibody (eBioscience, 14D3) was used in blocking or activating experiments on human samples (fig 7). Nat Commun (2015) ncbi
mouse monoclonal (14D3)
  • flow cytometry; human
Invitrogen CTLA4 antibody (eBioscience, 14D3) was used in flow cytometry on human samples . Hum Immunol (2015) ncbi
mouse monoclonal (14D3)
  • flow cytometry; human
Invitrogen CTLA4 antibody (eBioscience, 14D3) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (14D3)
  • flow cytometry; human
In order to developed a strategy to expand umbilical cord blood T cells and test their effects after transplantation, Invitrogen CTLA4 antibody (eBioscience, 14D3) was used in flow cytometry on human samples . Leukemia (2015) ncbi
Articles Reviewed
  1. Paulsen E, Kilvaer T, Rakaee M, Richardsen E, Hald S, Andersen S, et al. CTLA-4 expression in the non-small cell lung cancer patient tumor microenvironment: diverging prognostic impact in primary tumors and lymph node metastases. Cancer Immunol Immunother. 2017;66:1449-1461 pubmed publisher
  2. Caturegli P, Di Dalmazi G, Lombardi M, Grosso F, Larman H, Larman T, et al. Hypophysitis Secondary to Cytotoxic T-Lymphocyte-Associated Protein 4 Blockade: Insights into Pathogenesis from an Autopsy Series. Am J Pathol. 2016;186:3225-3235 pubmed publisher
  3. Chen H, Händel N, Ngeow J, Muller J, Huhn M, Yang H, et al. Immune dysregulation in patients with PTEN hamartoma tumor syndrome: Analysis of FOXP3 regulatory T cells. J Allergy Clin Immunol. 2017;139:607-620.e15 pubmed publisher
  4. Miles B, Miller S, Folkvord J, Kimball A, Chamanian M, Meditz A, et al. Follicular regulatory T cells impair follicular T helper cells in HIV and SIV infection. Nat Commun. 2015;6:8608 pubmed publisher
  5. Scottà C, Fanelli G, Hoong S, Romano M, Lamperti E, Sukthankar M, et al. Impact of immunosuppressive drugs on the therapeutic efficacy of ex vivo expanded human regulatory T cells. Haematologica. 2016;101:91-100 pubmed publisher
  6. Fricke F, Beaudouin J, Eils R, Heilemann M. One, two or three? Probing the stoichiometry of membrane proteins by single-molecule localization microscopy. Sci Rep. 2015;5:14072 pubmed publisher
  7. Patsoukis N, Bardhan K, Chatterjee P, Sari D, Liu B, Bell L, et al. PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation. Nat Commun. 2015;6:6692 pubmed publisher
  8. Rueda C, Wells C, Gisslen T, Jobe A, Kallapur S, Chougnet C. Effect of chorioamnionitis on regulatory T cells in moderate/late preterm neonates. Hum Immunol. 2015;76:65-73 pubmed publisher
  9. Bending D, Pesenacker A, Ursu S, Wu Q, Lom H, Thirugnanabalan B, et al. Hypomethylation at the regulatory T cell-specific demethylated region in CD25hi T cells is decoupled from FOXP3 expression at the inflamed site in childhood arthritis. J Immunol. 2014;193:2699-708 pubmed publisher
  10. Pegram H, Purdon T, van Leeuwen D, Curran K, Giralt S, Barker J, et al. IL-12-secreting CD19-targeted cord blood-derived T cells for the immunotherapy of B-cell acute lymphoblastic leukemia. Leukemia. 2015;29:415-22 pubmed publisher